Touchstone Diabetes Center

Recent Publications

    Unger RH, Cherrington AD (2012) Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover J Clin Invest. 2012 Jan 3; 122 (1):4-12.

    Chen L, Philippe J, Unger RH (2011) Glucagon responses of isolated α cells to glucose, insulin, somatostatin, and leptin.  Endocr Pract. 2011 Sep 1;17(5):819-25.

    Kruger, AJ, Yang, C, Lipson, KL, Pino, SC, Leif, JH, Hogan, CM, Whalen, BJ, Guberski, DL, Unger, RH, Greiner, DL, Rossini, AA, Bortell, R (2011) Leptin Treatment Cofers Clinical Benefit at Multiple stages of Virally Induced Type 1 Diabetes in BB Rats. Autoimmunity, 2011 Mar;44(2):137-48.

    Lee Y, Wang MY, Du XQ, Charron MJ, Unger RH.(2011) Glucagon receptor knockout prevents insulin-deficient type 1  diabetes in mice. Diabetes. 2011 Feb;60(2):391-7.

    Yilmaz C, Ravikumar P, Bellotto DJ, Unger RH, Hsia CC(2010) Fatty diabetic lung: functional impairment in a model of metabolic syndrome. J Appl Physiol. 2010 Dec;109(6):1913-9.

    Unger, RH and Orci, L. (2010). The Paracrinology of Islets and the Paracrinopathy of Diabetes. PNAS, Sep 14;107(37):16009-12

    Unger, RH and Scherer, PE (2010). Gluttony, Sloth, and the Metabolic Syndrome: A Roadmap to Lipotoxicity. Trends in Endocrinology & Medicine, Jun;21(6):345-52.

    Wang, M-Y, Chen, L., Clark, G, Lee, Y,  Stevens R, Ilkayeva, O, Wenner B, Bain J, Charron M, Newgard, C, Unger, RH. (2009)  Leptin Therapy in insulin-deficient Type I Diabetes.  PNAS, 2010 Mar;107(11):4813-4819.

    Vidal-Puig, A and Unger, RH. Special issue on lipotoxicity (Guest Editors). (2010). Biochim Biophys Acta, 2010 Mar;1801(3):207-8.

    Unger, RH, Clark, GO, Orci, L., Scherer, P. (2010)  Lipid Homeostasis, Lipotoxicity and the Metabolic Syndrome. Biochim Biophys Acta. 2010 Mar;1801(3):209-14.




image description